Osteopenia Unknown Status Phase 2 Trials for Zoledronic acid (DB00399)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00102908Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral DensityTreatment